Jenna Rannikko
jenna.h.rannikko@utu.fi |
Publications
- Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses (2025)
- OncoImmunology
(A1 Refereed original research article in a scientific journal) - Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments (2024)
- Cancer Immunology Research
(A1 Refereed original research article in a scientific journal) - Clinical landscape of macrophage-reprogramming cancer immunotherapies (2024)
- British Journal of Cancer
(A2 Refereed review article in a scientific journal ) - Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment (2024)
- Journal for Immunotherapy of Cancer
(A1 Refereed original research article in a scientific journal) - Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors : The phase I/II first-in-human MATINS trial (2023)
- Cell Reports Medicine
(A1 Refereed original research article in a scientific journal) - The effect of acute exercise on circulating immune cells in newly diagnosed breast cancer patients (2023)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - A distinct M2 macrophage infiltrate and transcriptomic profile decisively influence adipocyte differentiation in lipedema (2022)
- Frontiers in Immunology
(A1 Refereed original research article in a scientific journal) - Nonclinical Characterization of Bexmarilimab, a Clever-1-Targeting Antibody for Supporting Immune Defense Against Cancers (2022)
- Molecular Cancer Therapeutics
(A1 Refereed original research article in a scientific journal) - Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial (2021)
- Clinical Cancer Research
(A1 Refereed original research article in a scientific journal)